InMed Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: INM
Share price (8/5/26): $1.40
Market cap (8/5/26): $3.926 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 425 6 pages Amendment No. 1 to the Agreement and Plan of Merger and Reorganization

from 8-K 6 pages Amendment No. 1 to the Agreement and Plan of Merger and Reorganization

from 8-K 113 pages Agreement and Plan of Merger and Reorganization Among: Mentari Therapeutics, Inc.; Indigo Merger Sub Corp.; Indigo Merger Sub II, LLC; and InMed Pharmaceuticals Inc. Dated as of May 19, 2026

from 425 113 pages Agreement and Plan of Merger and Reorganization Among: Mentari Therapeutics, Inc.; Indigo Merger Sub Corp.; Indigo Merger Sub II, LLC; and InMed Pharmaceuticals Inc. Dated as of May 19, 2026

from 8-K 86 pages Amended and Restated Agreement and Plan of Reorganization Among InMed Pharmaceuticals Inc., Baymedica, LLC, Baymedica, Inc., the Stockholders and Founders Listed on the Signature Pages Hereto, and Bm Rep, LLC Dated as of October 13, 2021

from 10-K 88 pages Agreement and Plan of Reorganization Among InMed Pharmaceuticals Inc., Inmed LLC, Baymedica, Inc., the Stockholders and Founders Listed on the Signature Pages Hereto, and Bm Rep, LLC Dated as of September 10, 2021